JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janatova, J.
Right arrow Articles by Hunter, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janatova, J.
Right arrow Articles by Hunter, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Heterogeneity of Bovine Albumin with Respect to Sulfhydryl and Dimer Content

J. Janatova 1, J. K. Fuller 1, and M. J. Hunter 1

From the 1 From The Institute of Science and Technology, Biophysics Research Division, and Department of Biological Chemistry, Medical School, University of Michigan, Ann Arbor, Michigan 48104

A relatively fresh bovine plasma albumin (BPA) preparation (0.65 sulfhydryl group per albumin molecule; 5 to 6% dimer) and an old bovine mercaptalbumin (BMA) preparation (0.72 sulfhydryl group per albumin molecule; 8 to 9% dimer) were fractionated in a phosphate gradient on DEAE-Sephadex A-50. Two dimer fractions were obtained. One dimer fraction had a relatively high sulfhydryl content and could not be converted to monomer by treatment with thioglycolate. The other dimer fraction was essentially sulfhydryl-free, and approximately 50% of this dimer could be converted to monomer on treatment with thioglycolate. The first type of dimer predominated in the BPA preparation, while the second type of dimer was the major dimer component of the BMA preparation.

BPA monomer fractions of varying sulfhydryl content were obtained. The first major fraction to be eluted was mercaptalbumin. Non-mercaptalbumin fractions were retarded in their elution from the column, and it was not possible to achieve more than partial regeneration of the sulfhydryl group of the more retarded non-mercaptalbumin fractions by treatment with 0.05 m thioglycolate. These results agree with the findings of Hartley, Peterson, and Sober and of Andersson.

The BMA monomer fractions were similar in their elution volume and sulfhydryl content to the BPA fractions; as with the BPA non-mercaptalbumin fractions, the more retarded the albumin monomer fraction, the lower the sulfhydryl content after treatment with 0.05 m thioglycolate.

The similarities in the behavior of the BPA and BMA non-mercaptalbumin monomer fractions are somewhat surprising since the presence of these non-mercaptalbumin fractions in plasma albumin has been shown to be due to mixed disulfide formation between mercaptalbumin and plasma cysteine and glutathione. It is difficult to see how the BMA non-mercaptalbumin monomer fractions could be present owing to such mixed disulfide formation, since the BMA preparation originally contained one sulfhydryl group per albumin molecule and has not since been in contact with small molecule thiols. Some oxidative pathway other than disulfide formation must be operative in the formation of non-mercaptalbumin monomer.

Submitted on January 15, 1968


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. J. Reigstad, H. M. Sande, O. Fluge, O. Bruland, A. Muga, J. E. Varhaug, A. Martinez, and J. R. Lillehaug
Platelet-derived Growth Factor (PDGF)-C, a PDGF Family Member with a Vascular Endothelial Growth Factor-like Structure
J. Biol. Chem., May 2, 2003; 278(19): 17114 - 17120.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
N. A. Turner, D. J. H. Gaskin, A. T. Yagnik, J. A. Littlechild, and E. N. Vulfson
Enantioselectivity of recombinant Rhizomucor miehei lipase in the ring opening of oxazolin-5(4H)-ones
Protein Eng. Des. Sel., April 1, 2001; 14(4): 269 - 278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Ammit and C. O'Neill
Studies of the Nature of the Binding by Albumin of Platelet-activating Factor Released from Cells
J. Biol. Chem., July 25, 1997; 272(30): 18772 - 18778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Y. Zhang, A.-M. Xu, M. Nomen, M. Walsh, J. F. Keaney Jr., and J. Loscalzo
Nitrosation of Tryptophan Residue(s) in Serum Albumin and Model Dipeptides. BIOCHEMICAL CHARACTERIZATION AND BIOACTIVITY
J. Biol. Chem., June 14, 1996; 271(24): 14271 - 14279.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ferreras, J. G. Gavilanes, C. López-Otín, and J. M. García-Segura
Thiol-Disulfide Exchange of Ribonuclease Inhibitor Bound to Ribonuclease A
J. Biol. Chem., December 1, 1995; 270(48): 28570 - 28578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sun, H. Li, A. B. Mason, R. C. Woodworth, and P. J. Sadler
Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
J. Biol. Chem., March 16, 2001; 276(12): 8829 - 8835.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1968 by the American Society for Biochemistry and Molecular Biology.